- Home
- CVM vs ACHL Comparison
CVM vs ACHL Comparison
Compare CVM & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- ACHL
- Stock Information
- Founded
- CVM 1983
- ACHL 2016
- Country
- CVM United States
- ACHL United Kingdom
- Employees
- CVM N/A
- ACHL N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVM Health Care
- ACHL Health Care
- Exchange
- CVM Nasdaq
- ACHL Nasdaq
- Market Cap
- CVM 40.1M
- ACHL 46.0M
- IPO Year
- CVM 1987
- ACHL 2021
- Fundamental
- Price
- CVM $0.40
- ACHL $1.38
- Analyst Decision
- CVM
- ACHL Buy
- Analyst Count
- CVM 0
- ACHL 2
- Target Price
- CVM N/A
- ACHL $4.00
- AVG Volume (30 Days)
- CVM 1.2M
- ACHL 1.9M
- Earning Date
- CVM 02-14-2025
- ACHL 04-03-2025
- Dividend Yield
- CVM N/A
- ACHL N/A
- EPS Growth
- CVM N/A
- ACHL N/A
- EPS
- CVM N/A
- ACHL N/A
- Revenue
- CVM N/A
- ACHL N/A
- Revenue This Year
- CVM N/A
- ACHL N/A
- Revenue Next Year
- CVM N/A
- ACHL N/A
- P/E Ratio
- CVM N/A
- ACHL N/A
- Revenue Growth
- CVM N/A
- ACHL N/A
- 52 Week Low
- CVM $0.33
- ACHL $0.63
- 52 Week High
- CVM $2.50
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- CVM 45.54
- ACHL 72.41
- Support Level
- CVM $0.39
- ACHL $1.10
- Resistance Level
- CVM $0.68
- ACHL $1.41
- Average True Range (ATR)
- CVM 0.06
- ACHL 0.02
- MACD
- CVM 0.01
- ACHL 0.00
- Stochastic Oscillator
- CVM 18.86
- ACHL 90.48
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.